TotalMarketCap

Bolt Biotherapeutics

BOLTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$12.569 M

$6.53 -0.23%

Close of 6 Nov 2026

As of 6 Nov 2026, Bolt Biotherapeutics (BOLT) has a market capitalization of $12.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.70M

#3183 by revenue

Earnings

-$33.4M

Loss-making

Shares outstanding

1,926,345

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #401Radiopharm TheranosticsRADX$12.9M
  2. #402LipocineLPCN$12.6M
  3. #403Bolt BiotherapeuticsBOLT$12.6M
  4. #404Dare BioscienceDARE$12.3M
  5. #405BiofronteraBFRI$12.0M

What if Bolt Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$14,658,264

Per share 2,246,477× higher

Bitcoin $1.53T

$793,133.16

Per share 121,553× higher

Apple $5.02T

$2,603,782

Per share 399,047× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Bolt Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.